Selection of relevant evidence. The literature search outlined above identified 1937 records (1184 unique citations), a further three citations were identified by hand searching reference lists of other studies, and five records were identified in targeted website searches and the grey literature. The following exclusion criteria were applied: • Wrong publication or study type– excludes narrative reviews, conference abstracts and editorials, and non-comparative studies (i.e. single arm, observational studies) • Wrong population – excludes pharmacists practicing in pharmacies other than community pharmacies (i.e. in clinic or hospital pharmacies) • Wrong intervention – excludes studies of interventions that do not align with CIs as described in Section 3.1.1 (e.g. structured medication reviews, services exceeding 15 minutes duration, specific interventions or programs requiring protocol training) • Wrong comparator – excludes studies that do not include a comparator group of delivery of services without the CI • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1 • Not in English – excludes studies not published in English language or those that do not include at least some information (e.g. a summary) in English The exclusion of citations from the searches is presented in Table 3.3.
Selection of relevant evidence. The literature search outlined above identified 1976 unique citations. The following exclusion criteria were applied: • Wrong publication type– excludes narrative reviews. • Wrong intervention – excludes studies that examined the use of DAAs or similar compliance aids as part of a more comprehensive pharmacy care program or were part of a multifaceted pharmacy intervention that included pharmacist’s medication follow-up, education, counselling, home visits, or refill reminders. Studies that evaluated the use of DAAs that are packed by the patient (or self-packed) were excluded. Studies that assessed the use of automated medication dispensing devices were excluded.5 • Wrong comparator – excludes studies that compared DAAs with other compliance aids. • Wrong population – excludes RACF patients, hospital inpatients, recently discharged patients, or patients with infectious disease requiring short treatment duration. • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1. • Not in English – excludes studies not published in English language or those that do not include at least some information (e.g. a summary) in English. • Superseded – excludes systematic reviews that have been updated. The exclusion of citations from the searches is presented in Table 3.3.
Selection of relevant evidence. The literature search outlined above identified 48 unique citations. The following a priori exclusion criteria were applied: • Wrong population – excludes residential aged care facility (RACF) patients and hospital inpatients. • Wrong intervention – excludes studies that did not examine a SS service or similar intervention, and studies that examined the supply of medicines related to opioid substitution therapy. • Wrong comparator – excludes studies that compared SS with other pharmacy-led programs. • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1.
